HEALTH RELATED QUALITY OF LIFE AND SYMPTOMS IN AN INTERNATIONAL PHASE III TRIAL OF LONG TERM VERSUS SHORT-TERM ANDROGEN SUPPRESSION AND RADIATION THERAPY FOR LOCALLY ADVANCED PROSTATE CANCER (EORTC TRIAL 22961)

被引:0
|
作者
Collette, L. [1 ]
Mauer, M. [2 ]
Bolla, M. [3 ]
Van Tienhoven, G. [4 ]
De Reijke, T. M. [5 ]
Van Den Bergh, A. C. M. [6 ]
Oddens, J. [7 ]
Poortmans, P. M. P. [8 ]
Bottomley, A. [9 ]
机构
[1] Eortc Data Ctr, Dept Stat, Brussels, Belgium
[2] EORTC Headquarters, Dept Stat, Brussels, Belgium
[3] CHR Grenoble La Tronche, Dept Radiotherapy, Grenoble, France
[4] Acad Med Centrum, Dept Radiotherapy, Amsterdam, Netherlands
[5] Acad Med Centrum, Dept Urol, Amsterdam, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Radiotherapy, NL-9713 AV Groningen, Netherlands
[7] Jeroen Bosch Ziekenhuis, Dept Urol, Shertogenbosch, Netherlands
[8] Dr Bernard Verbeeten Inst, Dept Radiotherapy, Tilburg, Netherlands
[9] EORTC Headquarters, Dept Qual Life, Brussels, Belgium
关键词
D O I
10.1016/S1569-9056(09)60737-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:307 / 307
页数:1
相关论文
共 50 条
  • [41] Radiotherapy with or without short term androgen deprivation therapy in intermediate risk prostate cancer: final results of a phase III randomized trial
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Thu Van Nguyen
    Vavassis, Peter
    Brassard, Marc-Andre
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Wilke, Derek
    Souhami, Luis
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 : 8 - 8
  • [42] Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial
    Abdenour Nabid
    Nathalie Carrier
    André-Guy Martin
    Jean-Paul Bahary
    Peter Vavassis
    Sylvie Vass
    Boris Bahoric
    Robert Archambault
    François Vincent
    Redouane Bettahar
    Luis Souhami
    Quality of Life Research, 2025, 34 (3) : 725 - 737
  • [43] Does short-term ADT before and during radiation therapy improve outcomes in locally advanced prostate cancer?
    Antonarakis, Emmanuel S.
    Eisenberger, Mario A.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (09): : 480 - 481
  • [44] Does short-term ADT before and during radiation therapy improve outcomes in locally advanced prostate cancer?
    Emmanuel S Antonarakis
    Mario A Eisenberger
    Nature Clinical Practice Urology, 2008, 5 : 480 - 481
  • [45] Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy -: A phase III EORTC study
    Bolla, M
    Collette, L
    Gonzalez, D
    Warde, P
    Dubois, JB
    Mirimanoff, R
    Storme, G
    Bernier, J
    Kuten, A
    Plérart, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S82 - S82
  • [46] Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 Trial
    Maddalo, Marta
    Borghetti, Paolo
    Tomasini, Davide
    Corvo, Renzo
    Bonomo, Pierluigi
    Petrucci, Alessia
    Paiar, Fabiola
    Lastrucci, Luciana
    Bonu, Marco Lorenzo
    Greco, Diana
    Costa, Loredana
    Pegurri, Ludovica
    Triggiani, Luca
    Belgioia, Liliana
    Desideri, Isacco
    Grisanti, Salvatore
    Buglione, Michela
    Magrini, Stefano Maria
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (03): : 469 - 477
  • [47] Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
    Denham, James W.
    Steigler, Allison
    Lamb, David S.
    Joseph, David
    Turner, Sandra
    Matthews, John
    Atkinson, Chris
    North, John
    Christie, David
    Spry, Nigel A.
    Tai, Keen-Hun
    Wynne, Chris
    D'Este, Catherine
    LANCET ONCOLOGY, 2011, 12 (05): : 451 - 459
  • [48] Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled Trial
    Roy, Soumyajit
    Spratt, Daniel E.
    Morgan, Scott C.
    Zhou, Michael
    D'Souza, Leah A.
    Drogos, Fletcher
    Malone, Julia
    Grimes, Scott
    Gualano, Christopher
    MacRae, Robert
    Mukherjee, Dibya
    Malone, Shawn
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (04): : 880 - 889
  • [49] Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza, A.
    Macias, V.
    Casas, F.
    Pedro-Olive, A.
    Villa, S.
    Boladeras, A.
    Vazquez de La Torre, M. L.
    Martin de Vidales, C.
    Calvo, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Patient-Reported Outcomes From a Phase 3 Randomized Controlled Trial Exploring Optimal Sequencing of Short-Term Androgen Deprivation Therapy With Prostate Radiation Therapy in Localized Prostate Cancer
    Roy, Soumyajit
    Grimes, Scott
    Morgan, Scott Carlyle
    Eapen, Libni
    Malone, Julia
    Craig, Julia
    Spratt, Daniel Eidelberg
    Malone, Shawn
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (04): : 1101 - 1113